Abdul Basith Khan, M., Hashim, M. J., King, J. K., Govender, R. D., Mustafa, H., & Al Kaabi, J. (2020). Epidemiology of type 2 diabetes—global burden of disease and forecasted trends. Journal of epidemiology and global health, 10(1), 107-111.
Al-Samerria, S., & Radovick, S. (2021). The role of insulin-like growth factor-1 (IGF-1) in the control of neuroendocrine regulation of growth. Cells, 10(10), 2664.
Alizadeh, A. A., Rahmani-Nia, F., Mohebbi, H., & Zakerkish, M. (2016). Acute aerobic exercise and plasma levels of orexin a, insulin, glucose, and insulin resistance in males with type 2 diabetes. Jundishapur Journal of Health Sciences, 8(1).
Awuchi, C. G., Echeta, C. K., & Igwe, V. S. (2020). Diabetes and the nutrition and diets for its prevention and treatment: A systematic review and dietetic perspective. Health Sciences Research, 6(1), 5-19.
Barcelos, R. P., Lima, F. D., Carvalho, N. R., Bresciani, G., & Royes, L. F. (2020). Caffeine effects on systemic metabolism, oxidativeinflammatory pathways, and exercise performance. Nutrition Research, 80, 1-17.
Barone, E., Di Domenico, F., Perluigi, M., & Butterfield, D. A. (2021). The interplay among oxidative stress, brain insulin resistance and AMPK dysfunction contribute to neurodegeneration in type 2 diabetes and Alzheimer disease. Free Radical Biology and Medicine, 176, 16-33.
Bertram, S., Brixius, K., & Brinkmann, C. (2016). Exercise for the diabetic brain: how physical training may help prevent dementia and
Alzheimer’s disease in T2DM patients. Endocrine, 53, 350-363.
Borges, M. E., Ribeiro, A. M., Pauli, J. R., Arantes, L. M., Luciano, E., de Moura, L. P., . . . Sibuya, C. Y. (2017). Cerebellar Insulin/IGF-1 signaling in diabetic rats: Effects of exercise training. Neuroscience letters, 639, 157-161.
Candeias, E., Sebastião, I., Cardoso, S., Carvalho, C., Santos, M. S., Oliveira, C. R., . . . Duarte, A. I. (2018). Brain GLP-1/IGF-1 signaling and autophagy mediate exendin-4 protection against apoptosis in type 2 diabetic rats. Molecular neurobiology, 55, 4030-4050.
Colberg, S. R., Sigal, R. J., Fernhall, B., Regensteiner, J. G., Blissmer, B. J., Rubin, R. R., . . . Braun, B. (2010). Exercise and type 2 diabetes: the
American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes care, 33(12), e147e167.
Colberg, S. R., Sigal, R. J., Yardley, J. E., Riddell, M. C., Dunstan, D. W., Dempsey, P. C., . . . Tate, D. F. (2016). Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes care, 39(11), 2065.
Daneshyar, S., Gharakhanlou, R., Nikooie, R., & Forutan, Y. (2014). The effect of high-fat diet and streptozotocin-induced diabetes and endurance training on plasma levels of calcitonin gene-related peptide and lactate in rats. Canadian Journal of Diabetes, 38(6), 461-465.
Daryabor, G., Atashzar, M. R., Kabelitz, D., Meri, S., & Kalantar, K. (2020). The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Frontiers in Immunology, 11, 1582.
Demir, S., Nawroth, P. P., Herzig, S., & Ekim Üstünel, B. (2021). Emerging targets in type 2 diabetes and diabetic complications. Advanced Science, 8(18), 2100275.
Duran, R., PANCUR, S., & Bahadori, F. (2022). The Effect of Type 2
Diabetes Mellitus on the Development of Alzheimer’s Disease and Its Molecular Mechanism. Bezmialem Science, 10(1).
El Assar, M., Álvarez-Bustos, A., Sosa, P., Angulo, J., & Rodríguez-Mañas, L. (2022). Effect of physical activity/exercise on oxidative stress and inflammation in muscle and vascular aging. International Journal of Molecular Sciences, 23(15), 8713.
Frier, B. C. (2009). The Influence of Exercise on Inflammation and IGF-1
Signaling in Diabetes. School of Graduate and Postdoctoral Studies, University of Western Ontario,
Gillett, M., Royle, P., Snaith, A., Scotland, G., Poobalan, A., Imamura, M., . . . Wyness, L. (2012). Non-pharmacological interventions to reduce the risk of diabetes in people with impaired glucose regulation: a systematic review and economic evaluation. Health technology assessment, 16(33).
Liu, Y., Yan, T., Chu, J. M.-T., Chen, Y., Dunnett, S., Ho, Y.-S., . . . Chang, R. C.-C. (2019). The beneficial effects of physical exercise in the brain and related pathophysiological mechanisms in neurodegenerative diseases. Laboratory Investigation, 99(7), 943-957. M Ashraf, G., H Greig, N., A Khan, T., Hassan, I., Tabrez, S., Shakil, S., . . . R Jabir, N. (2014). Protein misfolding and aggregation in Alzheimer’s disease and type 2 diabetes mellitus. CNS & Neurological DisordersDrug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(7), 1280-1293.
Min, H., Zhu, S., Safi, L., Alkourdi, M., Nguyen, B. H., Upadhyay, A., & Tran, S. D. (2023). Salivary Diagnostics in Pediatrics and the Status of Saliva-Based Biosensors. Biosensors, 13(2), 206.
Moham, S. (2010). The Effects of Obesity on the Relationships Among
Insulin-like Growth Factor 1 and Markers of Diabetes. Bowling Green State University,
Mohammadi, E., Fathi, M., Chehel Cheraghi, F., & Nazari, A. (2023). Effect of a Six-week Endurance Exercise Program and Empagliflozin Consumption on Some Structural and Functional Indices of the Heart in Male Diabetic Rats. Iranian Journal of Diabetes and Metabolism.
Mukhtar, Y., Galalain, A., & Yunusa, U. (2020). A modern overview on diabetes mellitus: a chronic endocrine disorder. European Journal of Biology, 5(2), 1-14.
Ortiz, G. G., Huerta, M., González-Usigli, H. A., Torres-Sánchez, E. D., Delgado-Lara, D. L., Pacheco-Moisés, F. P., . . . Velázquez-Brizuela, I. E. (2022). Cognitive disorder and dementia in type 2 diabetes mellitus. World Journal of Diabetes, 13(4), 319.
Pedersen, B. K. (2019). Physical activity and muscle–brain crosstalk. Nature Reviews Endocrinology, 15(7), 383-392.
Rosen, C. J., & Yakar, S. (2020). Growth hormone, insulin-like growth factors, and IGF binding proteins. Principles of bone biology, 9851015.
Sigal, R. J., Kenny, G. P., Wasserman, D. H., Castaneda-Sceppa, C., & White, R. D. (2006). Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes care, 29(6), 1433-1438.
Slattery, K., Bentley, D., & Coutts, A. J. (2015). The role of oxidative, inflammatory and neuroendocrinological systems during exercise stress in athletes: implications of antioxidant supplementation on physiological adaptation during intensified physical training. Sports Medicine, 45, 453-471.
Sonntag, W. E., Ramsey, M., & Carter, C. S. (2005). Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing research reviews, 4(2), 195-212.
Tomić, L. (2020). Diabetes as a risk factor for neurodegenerative diseases. University of Zagreb. School of Medicine. Department of Pharmacology,
Vardatsikos, G., Sahu, A., & Srivastava, A. K. (2009). The insulin-like growth factor family: molecular mechanisms, redox regulation, and clinical implications. Antioxidants & redox signaling, 11(5), 11651190.
Wu, Y., Ding, Y., Tanaka, Y., & Zhang, W. (2014). Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. International journal of medical sciences, 11(11), 1185.
Zalouli, V., Rajavand, H., Bayat, M., Khaleghnia, J., Sharifianjazi, F., Jafarinazhad, F., & Beheshtizadeh, N. (2023). Adult hippocampal neurogenesis (AHN) controls central nervous system and promotes peripheral nervous system regeneration via physical exercise. Biomedicine & Pharmacotherapy, 165, 115078.
Zanuso, S., Sacchetti, M., Sundberg, C. J., Orlando, G., Benvenuti, P., & Balducci, S. (2017). Exercise in type 2 diabetes: genetic, metabolic and neuromuscular adaptations. A review of the evidence. British journal of sports medicine.
Zemva, J., & Schubert, M. (2014). The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer’s disease: possible therapeutic implications. CNS & Neurological DisordersDrug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders), 13(2), 322-337.
Zhou, G., Yan, M., Guo, G., & Tong, N. (2019). Ameliorative effect of berberine on neonatally induced type 2 diabetic neuropathy via modulation of BDNF, IGF-1, PPAR-γ, and AMPK expressions. DoseResponse, 17(3), 1559325819862449.
)